New Hire Brings over 17 Years of Life Sciences Scientific Sales Experience to Cyntellect

SAN DIEGO–Cyntellect, Inc., a privately-held life sciences company leading the development and commercialization of microplate-based cytometry systems, announced today that it has appointed Gareth Jones as its European Director of Sales and Operations responsible for the sale of company products to life science research customers, including pharmaceutical and biotechnology in Europe, and for setting up Cyntellect’s European operations. Gareth joins Cyntellect from the position of Global Market Development Director for GE Healthcare’s Advanced Systems & Cellular Technologies Divisions, where he was responsible for building enterprise level business opportunities between GE Healthcare and its global pharmaceutical and biotech customers.

“Gareth brings a tremendous breadth of experience in sales and market development in the life science research markets, particularly in the cellular bioassay and analysis markets. His appointment to lead Cyntellect’s European operations will accelerate the commercialization of our products for applications in cell line development for biopharmaceuticals, drug discovery, and cancer research including key applications utilizing stem cells,” said David Burns, Cyntellect’s VP Sales & Marketing and Chief Operating Officer. “We are very pleased to have someone of Gareth’s qualities and experiences join the Cyntellect team.”

Whilst at GE Healthcare, Gareth was also instrumental in the identification and establishment of new businesses and services focused in the cellular reagent space. Prior to that, he was the Global Sales & Support Manager for Applied Biosystems’ Cell Biology & Functional Proteomics Division, where he was responsible for leading the global sales growth and support of new cellular screening technology in the drug discovery and biopharmaceutical markets. Gareth brings with him over 17 years of successful European sales, sales management and commercial development experience in taking new innovative products and solutions into the pharmaceutical drug discovery, biopharmaceutical, and academic markets. He holds an honors degree in molecular microbiology from University College of Wales Swansea.

About Cyntellect

Cyntellect, Inc. creates and commercializes best-in-class products to analyze and process living cells more efficiently and with far greater accuracy than any technology in use today. Cyntellect’s products are currently used to advance the state of life science research, biopharmaceutical production, stem cell research and drug discovery. The Company’s in situ microplate-based cytometry systems process cells with great precision and simplicity in their natural state, allowing cells to maintain their proper physiologic behavior. Cyntellect’s expanding cellular analysis and processing portfolio is expected to play an enabling role in the coming age of advanced cell-based diagnostics and therapeutics. For additional information please visit www.cyntellect.com.